Home › Leukemia › Tennessee › Memphis
Leukemia clinical trials in Memphis, TN
5 studies for Leukemia are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Prospective Trial of Dalbavancin-Based Prophylaxis in Children and Adolescents With High-Risk Leukemia
RecruitingPhase 1
- St. Jude Children's Research Hospital, Memphis
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- Baptist Clinical Research Institute, Memphis
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- Baptist Clinical Research Institute, Memphis
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RecruitingObservational studyHealthy volunteers welcome
- Baptist (BHMCC), Memphis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Memphis
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX28 studies
- Boston, MA25 studies
- New York City, NY19 studies
- Chicago, IL16 studies
- Los Angeles, CA16 studies
- Durham, NC13 studies
- Philadelphia, PA12 studies
- Columbus, OH12 studies
- Nashville, TN12 studies
- Baldwin Park, CA12 studies
- Milwaukee, WI11 studies
- Seattle, WA11 studies
Other studies in Memphis
- Cancer (all types)31 studies
- Non-Small Cell Lung Cancer23 studies
- Breast Cancer21 studies
- Lung Cancer18 studies
- Sickle Cell Disease18 studies
- Acute Lymphoblastic Leukemia16 studies
- Acute Myeloid Leukemia15 studies
- Heart Failure13 studies
- Colorectal Cancer11 studies
- Melanoma11 studies
- Soft Tissue Sarcoma11 studies
- Prostate Cancer11 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.